Medivolve Inc
Medivolve Inc. is a principal investment firm. It prefers to invest in healthcare technology, industrials, information technology. Medivolve Inc., formerly known as QuestCap Inc, was founded in 2005 and is based in Toronto, Canada.
Market Cap & Net Worth: Medivolve Inc (MEDVF)
Medivolve Inc (PINK:MEDVF) has a market capitalization of $162.12K ($162.12K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #42162 globally and #13664 in its home market, demonstrating a 200.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medivolve Inc's stock price $0.01 by its total outstanding shares 27019248 (27.02 Million).
Medivolve Inc Market Cap History: 2015 to 2025
Medivolve Inc's market capitalization history from 2015 to 2025. Data shows change from $567.40K to $162.12K (-20.07% CAGR).
Medivolve Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Medivolve Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.43x
Medivolve Inc's market cap is 0.43 times its annual revenue
0.69x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $2.67 Million | $17.64K | -$711.56K | 151.61x | N/A |
| 2019 | $2.19 Million | $-152.11K | -$2.72 Million | -14.39x | N/A |
| 2020 | $8.65 Million | $10.58 Million | -$37.78 Million | 0.82x | N/A |
| 2021 | $1.59 Million | $86.83 Million | -$6.61 Million | 0.02x | N/A |
| 2022 | $2.57 Million | $1.39 Million | -$18.36 Million | 1.85x | N/A |
| 2023 | $297.21K | $686.45K | -$16.46 Million | 0.43x | N/A |
Competitor Companies of MEDVF by Market Capitalization
Companies near Medivolve Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Medivolve Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Medivolve Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Medivolve Inc's market cap moved from $567.40K to $ 162.12K, with a yearly change of -20.07%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $162.12K | 0.00% |
| 2024 | $162.12K | -45.45% |
| 2023 | $297.21K | -88.42% |
| 2022 | $2.57 Million | +61.02% |
| 2021 | $1.59 Million | -81.56% |
| 2020 | $8.65 Million | +295.06% |
| 2019 | $2.19 Million | -18.18% |
| 2018 | $2.67 Million | -20.80% |
| 2017 | $3.38 Million | +66.67% |
| 2016 | $2.03 Million | +257.14% |
| 2015 | $567.40K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Medivolve Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $162.12K USD |
| MoneyControl | $162.12K USD |
| MarketWatch | $162.12K USD |
| marketcap.company | $162.12K USD |
| Reuters | $162.12K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.